Found 7 matching trials
Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. PHASE2 The present study will evaluate the concomitant administration of a Quadriv...
Show More Location
Northern Beaches Clinical Research
Learn More & Join Trial
Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects. PHASE2 The present study OVX836-006 aims principally to:
* Confirm feasibility of...
Show More Location
Paratus Clinical Research Central Coast
Learn More & Join Trial
Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years PHASE2 This Phase 2a clinical study is designed to evaluate the immunogenicity and...
Show More Location
Centre for Vaccinology (CEVAC)
Learn More & Join Trial
Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers. PHASE2 This Phase 2a clinical trial is designed to evaluate the immunogenicity and...
Show More Location
Centre for Vaccinology (CEVAC)
Learn More & Join Trial
Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects PHASE1 The present study is a first-in-man clinical trial evaluating OVX836, a rec...
Show More Location
Centre for the Evaluation of Vaccination, University of Antwerp
Learn More & Join Trial
Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg PHASE2 The present study will evaluate the efficacy, immunogenicity and safety of ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836 PHASE2 This phase 2a is designed to evaluate the anamnestic response of a booster ...
Show More Location
Centre for Vaccinology (CEVAC) Ghent University Hospital
Learn More & Join Trial